Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation.

Clinical genetics - 1 Sept 2007

Metcalfe K A, Poll A, O'Connor A, Gershman S, Armel S, Finch A, Demsky R, Rosen B, Narod S A

Abstract excerpt

For women who carry a mutation in BRCA1 or BRCA2, the risk of breast cancer is up to 87% by the age of 70. There are options available to reduce the risk of breast cancer; however, each option has both risks and benefits, which makes decision making difficult. The objective is to develop and pilot test a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation. The decision aid was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Decision Support Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BRCA2 gene

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Genetic Counseling

Share to Mutation

Share to Pilot Projects

Source

Identifiers

PMID: 17718858
DOI: 10.1111/j.1399-0004.2007.00859.x

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation.PMID 17718858Read ↗

Evaluation of two evidence-based decision aids for female BRCA1/2 mutation carriers in Germany: study protocol for a randomised controlled parallel-group trial.Semantic proximity Read ↗

Decision aids for female BRCA mutation carriers: a scoping review protocol.Semantic proximity Read ↗

Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy.Semantic proximity Read ↗

Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2.Semantic proximity Read ↗

Predictors of knowledge and knowledge gain after decision aid use among women with BRCA1/2 pathogenic variants.Semantic proximity Read ↗

A patient decision aid for risk-reducing surgery in premenopausal BRCA1/2 mutation carriers: Development process and pilot testing.Semantic proximity Read ↗

Development of Breast Cancer Choices: a decision support tool for young women with breast cancer deciding whether to have genetic testing for BRCA1/2 mutations.Semantic proximity Read ↗

Development of decision aids for female BRCA1 and BRCA2 mutation carriers in Germany to support preference-sensitive decision-making.Semantic proximity Read ↗

Development and pilot testing of a decision aid for men considering genetic testing for breast and/or ovarian cancer-related mutations (BRCA1/2).Semantic proximity Read ↗

The development of an online decision aid to support persons having a genetic predisposition to cancer and their partners during reproductive decision-making: a usability and pilot study.Semantic proximity Read ↗

Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation.Semantic proximity Read ↗

A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.